Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Return on Assets (2021 - 2025)

Coeptis Therapeutics Holdings has reported Return on Assets over the past 5 years, most recently at 0.81% for Q4 2025.

  • Quarterly results put Return on Assets at 0.81% for Q4 2025, up 41.0% from a year ago — trailing twelve months through Dec 2025 was 0.81% (up 41.0% YoY), and the annual figure for FY2025 was 0.98%, up 63.0%.
  • Return on Assets for Q4 2025 was 0.81% at Coeptis Therapeutics Holdings, up from 1.04% in the prior quarter.
  • Over the last five years, Return on Assets for COEPW hit a ceiling of 0.34% in Q4 2021 and a floor of 4.6% in Q4 2023.
  • Median Return on Assets over the past 5 years was 1.45% (2022), compared with a mean of 2.04%.
  • Biggest five-year swings in Return on Assets: plummeted -300bps in 2023 and later soared 338bps in 2024.
  • Coeptis Therapeutics Holdings' Return on Assets stood at 0.34% in 2021, then crashed by -440bps to 1.82% in 2022, then tumbled by -152bps to 4.6% in 2023, then surged by 74bps to 1.22% in 2024, then skyrocketed by 34bps to 0.81% in 2025.
  • The last three reported values for Return on Assets were 0.81% (Q4 2025), 1.04% (Q3 2025), and 0.98% (Q2 2025) per Business Quant data.